Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fink

Showing results (171-180 of 363) with videos related to

Pageof 37
Sort By:
Neurology|November 30, 2000
Mitochondrial analysis in autosomal dominant hereditary spastic paraplegiaP Hedera, S DiMauro, E Bonilla, et al.
Immunitat Und Infektion|June 1, 1983
[Immunomodulation by symptomaticly active antirheumatic agents]R Dreher, K Fink, H Seidel, et al.
Neurology|October 11, 1991
Allele-specific sequencing confirms novel prion gene polymorphism in Creutzfeldt-Jakob diseaseJ K Fink, J T Warren, I Drury, et al.
British Journal of Cancer|January 13, 2006
Mitochondrial DNA mutations in renal cell carcinomas revealed no general impact on energy metabolismD Meierhofer, J A Mayr, K Fink, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|August 27, 2017
[Preclinical use of mild therapeutic hypothermia after cardiac arrest by the emergency services in Baden-Württemberg, Germany]R Fantin, B Schmid, C Busche, et al.
Archives of Neurology|September 17, 2003
The second kindred with autosomal dominant distal myopathy linked to chromosome 14q: genetic and clinical analysisPeter Hedera, Elizabeth M Petty, Melanie R Bui, et al.
Pediatric Pulmonology|September 24, 2019
Evaluation of hospitalization data for the CFFPR-PHIS linked data setJonathan D Cogen, Anna V Faino, Frankline Onchiri, et al.
American Journal of Human Genetics|September 26, 2003
NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6)Shirley Rainier, Jing-Hua Chai, Debra Tokarz, et al.
Oncology|January 1, 1984
Combination chemotherapy with BCNU, vincristine, mitomycin-C and prednisone in refractory breast carcinoma. A pilot studyN J DiBella, D Garfield, K Fink, et al.
Neuropharmacology|November 5, 2016
The effect of sazetidine-A and other nicotinic ligands on nicotine controlled goal-tracking in female and male ratsS Charntikov, A M Falco, K Fink, et al.
Pageof 37

Showing results (171-180 of 363) with videos related to

Sort By:
Pageof 37
Neurology|November 30, 2000
Mitochondrial analysis in autosomal dominant hereditary spastic paraplegiaP Hedera, S DiMauro, E Bonilla, et al.
Immunitat Und Infektion|June 1, 1983
[Immunomodulation by symptomaticly active antirheumatic agents]R Dreher, K Fink, H Seidel, et al.
Neurology|October 11, 1991
Allele-specific sequencing confirms novel prion gene polymorphism in Creutzfeldt-Jakob diseaseJ K Fink, J T Warren, I Drury, et al.
British Journal of Cancer|January 13, 2006
Mitochondrial DNA mutations in renal cell carcinomas revealed no general impact on energy metabolismD Meierhofer, J A Mayr, K Fink, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|August 27, 2017
[Preclinical use of mild therapeutic hypothermia after cardiac arrest by the emergency services in Baden-Württemberg, Germany]R Fantin, B Schmid, C Busche, et al.
Archives of Neurology|September 17, 2003
The second kindred with autosomal dominant distal myopathy linked to chromosome 14q: genetic and clinical analysisPeter Hedera, Elizabeth M Petty, Melanie R Bui, et al.
Pediatric Pulmonology|September 24, 2019
Evaluation of hospitalization data for the CFFPR-PHIS linked data setJonathan D Cogen, Anna V Faino, Frankline Onchiri, et al.
American Journal of Human Genetics|September 26, 2003
NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6)Shirley Rainier, Jing-Hua Chai, Debra Tokarz, et al.
Oncology|January 1, 1984
Combination chemotherapy with BCNU, vincristine, mitomycin-C and prednisone in refractory breast carcinoma. A pilot studyN J DiBella, D Garfield, K Fink, et al.
Neuropharmacology|November 5, 2016
The effect of sazetidine-A and other nicotinic ligands on nicotine controlled goal-tracking in female and male ratsS Charntikov, A M Falco, K Fink, et al.
Pageof 37